| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document Help

Title:Chestnut-derived ellagitannins (FT50) protect against western diet-induced metabolic dysfunction and preserve beta cell function in mice
Authors:ID Skelin, Maša (Author)
ID Polšak, Nika (Author)
ID Jakopiček, Jasmina (Author)
ID Kovačič, Polona (Author)
ID Kopecky, Jan (Author)
ID Paradiž, Eva (Author)
ID Kerčmar, Jasmina (Author)
ID Križančić Bombek, Lidija (Author)
ID Dolenšek, Jurij (Author)
ID Stožer, Andraž (Author)
Files:.pdf RAZ_Skelin_Masa_2026.pdf (2,44 MB)
MD5: 8B79A79817C9A2FFDBD9E5B4613EDEB0
 
URL https://doi.org/10.3389/fendo.2026.1802808
 
URL https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2026.1802808/full
 
Language:English
Work type:Scientific work
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Abstract:Background: Western diet (WD) consumption accelerates the development of metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM). This study investigated whether chestnut-derived ellagitannins (FT50) modulate early metabolic alterations associated with WD feeding in C57BL/6J male mice. Methods: Male C57BL/6J mice were fed either a western diet (WD) or a WD supplemented with chestnut extract (FT50) for 12 weeks. Body weight, adiposity, glucose tolerance, and indices of insulin action were monitored throughout the study. Glucose and insulin homeostasis were assessed by measuring fasting glucose levels, insulin levels, and the HOMA-IR index. Pancreatic function was evaluated by ex vivo Ca2+ imaging in pancreas tissue slices to assess beta cell activation dynamics and islet network coordination. Results: WD feeding induced significant body weight gain, adiposity, hyperglycemia, glucose intolerance, changes consistent with impaired insulin action, and partially compensatory hyperinsulinemia. Supplementation with FT50 prevented weight gain and fat accumulation, reduced organ hypertrophy, and was associated with improved glucose and insulin-related parameters without affecting the caloric intake. FT50-fed mice showed improved glucose tolerance from week 4 onward, accompanied by a lower HOMA-IR values and reduced hyperinsulinemia, consistent with improved indirect markers of insulin action relative to WD-fed mice. Ex vivo Ca2+ imaging in pancreas tissue slices revealed that in FT50-fed mice, beta cells have higher activation thresholds, longer activation delays, and lower Ca2+ activity during the plateau phase, while their network coordination is preserved. Conclusions: In sum, these effects indicate reduced beta cell excitability and are consistent with an attenuation of early metabolic alterations under WD conditions. Overall, these findings suggest that FT50 supplementation modulates early WD-induced metabolic changes in male mice. However, the study is limited to early-stage alterations, does not address later stages of metabolic disease, and does not establish direct effects on insulin sensitivity. Within these constraints, chestnut extract represents a potentially promising bioactive dietary intervention for modulating early metabolic responses to WD.
Keywords:beta cells, calcium imaging, ellagitannins, glucose intolerance, insulin resistance, metabolic syndrome, mouse model, western diet
Publication status:Published
Publication version:Version of Record
Submitted for review:02.04.2026
Article acceptance date:08.04.2026
Publication date:30.04.2026
Publisher:Frontiers
Year of publishing:2026
Number of pages:str. 1-18
Numbering:Letn. 17, Apr. 2026
PID:20.500.12556/DKUM-98154 New window
UDC:612.349.7
ISSN on article:1664-2392
COBISS.SI-ID:278686211 New window
DOI:10.3389/fendo.2026.1802808 New window
Publication date in DKUM:21.05.2026
Views:173
Downloads:3
Metadata:XML DC-XML DC-RDF
Categories:Misc.
:
Copy citation
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share



Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Frontiers in endocrinology
Publisher:Frontiers Research Foundation
ISSN:1664-2392
COBISS.SI-ID:3340154 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P3-0396-2019
Name:Celične in tkivne mreže

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:I0-0029-2022
Name:Infrastrukturna dejavnost Univerze v Mariboru

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-60062-2025
Name:Vpliv aminokislin na delovanje omrežja celic v Langerhansovih otočkih

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:N3-0484-2026
Name:Mehanistični vpogled v eksokrino–endokrino sodelovanje: endokrina disfunkcija pri pankreatitisu in spremembe v eksokrini funkciji pri sladkorni bolezni

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J1-70030
Name:Razvoj Langerhansovih otočkov in vitro za analizo endokrine funkcije

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica